Mark Gelder

Mark Gelder

Plus aucun poste en cours
69 ans
Health Technology
Health Services
Consumer Services

Profil

Mark Stephen Gelder worked as an Executive Medical Director, Chief Medical Officer, Vice President of Medical Affairs & Oncology, and Vice President of Clinical Development in various pharmaceutical companies such as Labcorp Drug Development, Heron Therapeutics, Onconova Therapeutics, Accelovance, and Inovio Pharmaceuticals.
He also served as the Chief Medical Officer at Elevar Therapeutics and Pierian Biosciences LLC.
Gelder completed his undergraduate degree at Colgate University and earned his doctorate from The University of Virginia School of Medicine.

Anciens postes connus de Mark Gelder

SociétésPosteFin
TRAWS PHARMA, INC. Directeur Technique/Scientifique/R&D 06/04/2023
Corporate Officer/Principal 01/06/2021
COVANCE INC. Corporate Officer/Principal 01/05/2020
HERON THERAPEUTICS, INC. Directeur Technique/Scientifique/R&D 23/01/2015
Corporate Officer/Principal -
Voir l'expérience en détail de Mark Gelder

Formation de Mark Gelder

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

11

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Services

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Services

  1. Bourse
  2. Insiders
  3. Mark Gelder
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT